Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.3 (
ATPase
)
65,361
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Specific language impairment (SLI) is defined as failure to acquire normal language skills despite adequate intelligence and environmental stimulation. Although SLI disorders are often heritable, the genetic basis is likely to involve a number of risk factors. This study describes a 7-year-old girl carrying an inherited paracentric inversion of the long arm of chromosome 3 [46XX, inv(3)(q25.32-q29)] having clinically defined expressive and receptive language delay. Fluorescence in situ hybridization (FISH) with locus-specific bacterial artificial chromosome clones (BACs) as probes was used to characterize the inverted chromosome 3. The proximal and distal inversion breakpoint was found to reside between markers D3S3692/D3S1553 and D3S3590/D3S2305, respectively.
ATP13A4
, a novel gene coding for a cation-transporting P-type
ATPase
, was found to be disrupted by the distal breakpoint. The
ATP13A4
gene was shown to comprise a 3591-bp transcript encompassing 30 exons spanning 152 kb of the genomic DNA. This study discusses the characterization of
ATP13A4
and its possible involvement in speech-language disorder.
...
PMID:Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay. 1592 80
ATP13A4
is a member of the subfamily of P5-type ATPases. P5-type ATPases are the least studied of the P-type
ATPase
subfamilies with no ion specificities assigned to them. In order to elucidate
ATP13A4
function, we studied the protein's subcellular localization and tested whether it is involved in calcium regulation. The intracellular calcium concentration was measured in COS-7 cells over-expressing mouse
ATP13A4
using ratiometric calcium imaging with fura-2 AM as a calcium indicator. The results of this study show that
ATP13A4
is localized to the endoplasmic reticulum (ER). Furthermore, we demonstrate that over-expression of
ATP13A4
in COS-7 cells caused a significant increase in the intracellular calcium level. Interestingly, over-expression of the sequence variant containing a substitution of aspartic acid for a glutamic acid (E646D), previously found in patients with autism spectrum disorder (ASD), did not increase the free cellular calcium likely due to the mutation. In this study, we also describe the expression of
ATP13A4
during mouse embryonic development. Quantitative real-time PCR revealed that
ATP13A4
was highly expressed at embryonic days 15-17, when neurogenesis takes place. The present study is the first to provide further insights into the biological role of a P5-type
ATPase
. Our results demonstrate that
ATP13A4
may be involved in calcium regulation and that its expression is developmentally regulated. Overall, this study provides support for the hypothesis that
ATP13A4
may play a vital role in the developing nervous system and its impairment can contribute to the symptoms seen in ASD.
...
PMID:The E646D-ATP13A4 mutation associated with autism reveals a defect in calcium regulation. 1973 Oct 10
Several human P5-type transport ATPases are implicated in neurological disorders, but little is known about their physiological function and properties. Here, we investigated the relationship between the five mammalian P5 isoforms ATP13A1-5 in a comparative study. We demonstrated that ATP13A1-4 isoforms undergo autophosphorylation, which is a hallmark P-type
ATPase
property that is required for substrate transport. A phylogenetic analysis of P5 sequences revealed that ATP13A1 represents clade P5A, which is highly conserved between fungi and animals with one member in each investigated species. The ATP13A2-5 isoforms belong to clade P5B and diversified from one isoform in fungi and primitive animals to a maximum of four in mammals by successive gene duplication events in vertebrate evolution. We revealed that ATP13A1 localizes in the endoplasmic reticulum (ER) and experimentally demonstrate that ATP13A1 likely contains 12 transmembrane helices. Conversely, ATP13A2-5 isoforms reside in overlapping compartments of the endosomal system and likely contain 10 transmembrane helices, similar to what was demonstrated earlier for ATP13A2. ATP13A1 complemented a deletion of the yeast P5A
ATPase
SPF1, while none of ATP13A2-5 could complement either the loss of SPF1 or that of the single P5B
ATPase
YPK9 in yeast. Thus, ATP13A1 carries out a basic ER function similar to its yeast counterpart Spf1p that plays a role in ER related processes like protein folding and processing. ATP13A2-5 isoforms diversified in mammals and are expressed in the endosomal system where they may have evolved novel complementary or partially redundant functions. While most P5-type ATPases are widely expressed, some P5B-type ATPases (
ATP13A4
and ATP13A5) display a more limited tissue distribution in the brain and epithelial glandular cells, where they may exert specialized functions. At least some P5B isoforms are of vital importance for the nervous system, since ATP13A2 and
ATP13A4
are linked to respectively Parkinson disease and autism spectrum disorders.
...
PMID:Parkinson disease related ATP13A2 evolved early in animal evolution. 2950 81